A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. | MicrobiomeTrials← Back to trialsNCT07356453
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-07-22Est. Completion: 2027-06
Enrollment target: 40 participants Locations- Stanford University Medical Center, Palo Alto, California, United States
- University of California, San Francisco, San Francisco, California, United States
- START - Midwest, Grand Rapids, Michigan, United States
- Washington University St. Louis, St Louis, Missouri, United States
- Knight Cancer Institute, Portland, Oregon, United States
- University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
- START - San Antonio, San Antonio, Texas, United States
- NEXT - Virginia Cancer Specialists, Fairfax, Virginia, United States
Other microbiome trials you might be interested in
Advanced Solid TumorMetastatic Solid Tumor
The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine f…
Hamburg, GermanyEst. completion Dec 2026
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell Carcinoma
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
Stage II Laryngeal Cancer AJCC v8
Stage II Lip and Oral Cavity Cancer AJCC v8
Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This phase II trial tests the addition of chemotherapy, with carboplatin and paclitaxel, or chemo-immunotherapy, with ca…
Tucson, United StatesEst. completion Feb 1, 2033
Metastatic Breast Cancer
This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with met…
Duarte, United StatesEst. completion Sep 30, 2030